Skip to main content
Erschienen in: Reactions Weekly 1/2018

01.06.2018 | Case report

Cannabidiol/tacrolimus interactions

Elevated serum creatinine and tacrolimus toxicity: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (FDA MedWatch definition) when the patient outcome is:
  • * Drug interaction
Literatur
Zurück zum Zitat Leino A, et al. Evidence of a clinically significant drug-drug interaction between cannabidiol and tacrolimus: A case report. American Journal of Transplantation 18 (Suppl. 4): 744-745 (plus poster) abstr. B331, Jun 2018. Available from: URL: http://doi.org/10.1111/ajt.14918 [abstract] - USA Leino A, et al. Evidence of a clinically significant drug-drug interaction between cannabidiol and tacrolimus: A case report. American Journal of Transplantation 18 (Suppl. 4): 744-745 (plus poster) abstr. B331, Jun 2018. Available from: URL: http://​doi.​org/​10.​1111/​ajt.​14918 [abstract] - USA
Metadaten
Titel
Cannabidiol/tacrolimus interactions
Elevated serum creatinine and tacrolimus toxicity: case report
Publikationsdatum
01.06.2018
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2018
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-018-47438-x

Weitere Artikel der Ausgabe 1/2018

Reactions Weekly 1/2018 Zur Ausgabe

Case report

Heparin

Case report

Pembrolizumab

Case report

Hydralazine

Case report

Clozapine